Back to search

Article

Targeted internalization and activation of glycosidic switch liposomes by an EphA2 PEG engager increases therapeutic efficacy against lung cancer

2024-02-23

Abstract excerpt

Glycosidic switch liposome (GSL) technology uses a reversible glucuronide ester to efficiently encapsulate and stably retain potent anticancer drugs in liposomes. Parental drug is generated by enzymatic hydrolysis of the glucuronide switch in the lysosomes of target cells. Here we investigated if bispecific molecules simultaneously targeting polyethylene glycol (PEG) on GSL and an internalizing tumor antigen could...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1d13eb8d-77b1-56a0-8a40-b1f6dca2a327
DOI
10.21203/rs.3.rs-3938778/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeted internalization and activation of glycosidic switch liposomes by an EphA2 PEG engager increases therapeutic efficacy against lung cancerDOI 10.21203/rs.3.rs-3938778/v1
Select a neighboring publication to make it the new centre.